🚀 What is Pub-Xel

Pub-Xel is a free, open-source initiative designed to streamline access to biomedical research and simplify how we manage and use it - whether you’re in the clinic, the lab, or both.

🧬 Pub-Xel OncoTwitter

Pub-Xel OncoTwitter identifies and classifies oncology articles published in selected top-tier journals, updates them daily in a public spreadsheet, and shares key clinical insights on X (formerly Twitter).

Stay up to date effortlessly. 📊 About OncoTwitter

• 🐦 Twitter feeds (see full list here):

• @Thoracic_PubMed – Thoracic, Head & Neck Cancers

  🆕 Article in @journal_CHEST
  🚨 Dual Cannabis & Tobacco Smoking in Young Lung Cancer Patients 🔬
  
  📚 Prospective "Environment and Lung Cancer" study
  👥 150 patients aged <60 with primary lung cancer (2021-2023)
  🩸 Smoking behavior confirmed by hair testing (nicotine, THC, CBD)
  🧑‍⚕️…

  — Thoracic Head Neck Cancer PubMed (@Thoracic_PubMed) September 28, 2025

• @BreastOncPubMed – Breast Cancer

  .@JAMAOnc
  Phase III RCT NATALEE 4-year analysis (n=5101). Ribociclib plus NSAI for HR+/ERBB2- early breast cancer (stage II-III) showed iDFS benefit (HR 0.72, 4-y iDFS 88.5% vs 83.6%) vs NSAI alone.
  PMID:40996773https://t.co/2gKakbn045

  — Breast Cancer PubMed (@BreastOncPubMed) September 28, 2025

💻 Pub-Xel App

Pub-Xel App brings PubMed integration directly into Microsoft Excel, allowing you to:

• 📥 Import PubMed data into Excel
• 📁 Attach and manage PDFs/supplemental files
• ⚡ Access files quickly across software via global hotkeys

Built to assist reference management throughout your career, not just one project.

• 🔍 About the App
• 💾 Download for Windows

🌱 Stay Connected

Want to contribute, collaborate, or give feedback?
✉️ Reach out: info@pubxel.org

Powered by automation + curiosity. Always evolving. Free forever.